We recently published an article titled, Jim Cramer’s Latest Lightning Round: 12 Stocks to Watch. In this article, we are ...

David Tsay, M.D., was appointed chief medical officer of Counterpart Health, a Clover Health subsidiary, this month. | Clover ...

Analyst Richard Close from Canaccord Genuity maintained a Buy rating on Clover Health Investments (CLOV – Research Report) and keeping ...

On Friday, Clover Health Investments Corp (CLOV) stock saw a modest uptick, ending the day at $4.07 which represents a slight increase of $0.12 or 3.04% from the prior close of $3.95. The stock opened ...

“We are proud to reaffirm our commitment to New Jersey by maintaining our affordable benefit-rich PPO plans for 2025,” said Jamie Reynoso, Clover’s CEO of Medicare Advantage. “At a time when many ...

Analyses of 2025 Medicare Advantage star ratings continue to pour in and not all of it bodes well for the conventional ...

UBS has recently initiated Clover Health Investments Corp (CLOV) stock to Neutral rating, as announced on October 7, 2024, according to Finviz. Earlier, on February 2, 2022, Cowen had raised the stock ...

A research team has identified a wealth of bioactive compounds in red clover (Trifolium pratense ) seeds and their oil, ...

FRANKLIN, Tenn., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today ...

Corn crops have a voracious appetite for nitrogen. Purdue University scientists are investigating whether mulching Kura ...

FRANKLIN, Tenn., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV) (“Clover” or “the Company”) has announced the debut of its 2025 Medicare Advantage (MA) plan offerings in ...